Clinical Trial Update: A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial in advanced breast cancer compares paclitaxel with bevacizumab to a regimen of gemcitabine, paclitaxel, and bevacizumab; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-07-27